000 | 02969cam a2200601 i 4500 | ||
---|---|---|---|
001 | on1162269802 | ||
003 | OCoLC | ||
005 | 20250508013016.0 | ||
006 | m d | ||
007 | cr ||||||||||| | ||
008 | 110729s2012 nyua ob 001 0 eng | ||
010 | _a 2020677743 | ||
040 |
_aDLC _beng _erda _cDLC _dOCLCF _dVLY _dOCLCO _dN$T _dYDXCP _dE7B _dNLGGC _dEBLCP _dDEBSZ _dLOA _dD6H _dMERUC _dAGLDB _dMOR _dPIFPO _dZCU _dU3W _dSTF _dWRM _dVTS _dCOCUF _dNRAMU _dVT2 _dICG _dINT _dWYU _dK6U _dDKC _dM8D _dUX1 _dUKCRE _dAJS _dHS0 _dOCLCA _dOCLCO _dOCLCQ _dOCLCO _dOCLCL _dTMA |
||
019 |
_a852159172 _a923669389 _a960207181 _a961604358 _a962578389 _a988469824 _a992052107 _a1037916371 _a1038633431 _a1045488844 _a1047672164 _a1055358558 _a1066553606 _a1081267124 _a1153509679 _a1227637190 |
||
020 |
_a9781621003069 _qebook |
||
020 | _a162100306X | ||
020 |
_z9781621001898 _qsoftcover |
||
020 | _z162100189X | ||
035 |
_a605433 _b(N$T) |
||
035 |
_a(OCoLC)1162269802 _z(OCoLC)852159172 _z(OCoLC)923669389 _z(OCoLC)960207181 _z(OCoLC)961604358 _z(OCoLC)962578389 _z(OCoLC)988469824 _z(OCoLC)992052107 _z(OCoLC)1037916371 _z(OCoLC)1038633431 _z(OCoLC)1045488844 _z(OCoLC)1047672164 _z(OCoLC)1055358558 _z(OCoLC)1066553606 _z(OCoLC)1081267124 _z(OCoLC)1153509679 _z(OCoLC)1227637190 |
||
050 | 0 | 0 | _aRM340 |
060 | 1 | 0 | _aQV 193 |
072 | 7 |
_aMED _x023000 _2bisacsh |
|
072 | 7 |
_aMED _x058170 _2bisacsh |
|
072 | 7 |
_aMED _x071000 _2bisacsh |
|
072 | 7 |
_aMED _x072000 _2bisacsh |
|
082 | 0 | 0 |
_a615.1/9 _223 |
049 | _aMAIN | ||
245 | 0 | 0 |
_aWarfarin monitoring : _bstandard practice and beyond / _ceditors, Gary W. Moore, Graeme Thomson, Dominic J. Harrington. |
264 | 1 |
_aNew York : _bNova Science Publishers, _c[2012] |
|
300 | _a1 online resource | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 1 | _aPharmacology-- research, safety testing, and regulation | |
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aDiscovery and mode of action of warfarin -- Standard laboratory monitoring of warfarin -- Clinical considerations -- Dosing and monitoring -- Beyond standard monitoring. | |
588 | _aDescription based on print version record. | ||
546 | _aEnglish. | ||
650 | 0 | _aWarfarin. | |
650 | 0 | _aDrug monitoring. | |
700 | 1 |
_aMoore, Gary, _cDr. _1https://id.oclc.org/worldcat/entity/E39PCjFP6FBKFyCyF8hvMFTCgq |
|
700 | 1 |
_aThomson, Graeme, _d1959- _1https://id.oclc.org/worldcat/entity/E39PCjqKW87rCWHF6KCJrDrd6X |
|
700 | 1 | _aHarrington, Dominic J. | |
830 | 0 | _aPharmacology-research, safety testing, and regulation series. | |
856 | 4 | 0 |
_3EBSCOhost (requires login) _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=605433 |
938 |
_aProQuest Ebook Central _bEBLB _nEBL3022643 |
||
938 |
_aebrary _bEBRY _nebr10729683 |
||
938 |
_aEBSCOhost _bEBSC _n605433 |
||
938 |
_aYBP Library Services _bYANK _n7078307 |
||
942 | _cCF | ||
994 |
_a92 _bN$T |
||
999 |
_c1481 _d1481 |